|
CN105287642A
|
|
Establishment of mouse tuberculosis natural dormant infection model preparation and drug evaluation methods
|
|
CN105145486A
|
|
Application of RAG2 gene knockout rat in establishing personalized tumor treatment model
|
|
CN104593418A
|
|
Method for establishing humanized rat drug evaluation animal model
|
|
CN104546839A
|
|
Novel application of quinolizidine alkaloid
|
|
CN104561321A
|
|
Ebola virus Reston subtype real-time fluorescence quantitative PCR detection primer pair and kit
|
|
CN104404171A
|
|
Liquid chip detection kit for H5N1 subtype influenza viruses
|
|
CN104388599A
|
|
MASA (multi-analyte suspension array) detection kit for influenza virus H5N1 subtype and H7N9 subtype
|
|
CN104404172A
|
|
Liquid chip detection kit for H7N9 subtype influenza viruses
|
|
CN104531675A
|
|
Method for in-vitro synthesis and activity detection on gRNA
|
|
CN104436172A
|
|
Method for preparing novel animal model of asthma
|
|
CN104263745A
|
|
Recombinant immunodeficiency plasmid and virus and application thereof
|
|
CN104977260A
|
|
Spectroscopy identification technology of blood samples of different species
|
|
CN103193865A
|
|
Sendai virus antigen peptide and application thereof in Sendai virus infection detection
|
|
CN103159834A
|
|
Sendai virus antigen peptide and application thereof in detecting Sendai virus infection
|
|
CN103159859A
|
|
Sendai virus antigen peptide composition and application thereof in detecting Sendai virus infection
|
|
CN103159833A
|
|
Sendai virus antigen peptide and application thereof in detecting Sendai virus infection
|
|
CN103110652A
|
|
Application of chebulagic acid in preparation of medicament for treating diseases resulted from human enterovirus type 71 infection
|
|
CN102872065A
|
|
Novel application of naringin
|
|
CN102885841A
|
|
Application of punicalagin
|
|
CN102670636A
|
|
Application of geraniin in preparing medicament for treating diseases caused by human enterovirus 71 type infection
|
